The Center for Early Detection and Interception of Blood Cancers, formerly the Center for Prevention of Progression, is the first-of-its-kind clinic for individuals who are at high risk for developing blood cancers due to precursor conditions.
Our goal is to increase early detection of blood cancers and their precursor conditions, and improve treatment options for patients with precursor conditions.
What Are Precursor Conditions?
Most blood cancers are preceded by precursor conditions — early phases of diseases that may develop into cancers such as chronic lymphocytic leukemia, lymphoma, and multiple myeloma. These conditions are sometimes found through routine blood tests, but often remain undiagnosed.
- Clonal hematopoiesis of indeterminate potential (CHIP)
- Clonal cytopenia of undetermined significance (CCUS)
Plasma Cell Precursors
- Monoclonal gammopathy of undetermined significance (MGUS)
- Smoldering multiple myeloma (SMM)
- Immunoglobulin M monoclonal gammopathy of undetermined significance (IgM MGUS)
- Smoldering Waldenström macroglobulinemia (SWM)
- Monoclonal B cell lymphocytosis (MBL)
- Lymphoid clonal hematopoiesis (Lymphoid-CH)
- Low-grade lymphomas such as marginal zone lymphoma (MZL) and follicular lymphomas
At the Center for Early Detection and Interception of Blood Cancers, we evaluate individuals diagnosed with these conditions — or at high risk for disease development — and work with patients to manage their risk of disease progression.